2021
DOI: 10.1016/j.ejca.2020.11.012
|View full text |Cite
|
Sign up to set email alerts
|

Unmet needs for relapsed or refractory Wilms tumour: Mapping the molecular features, exploring organoids and designing early phase trials – A collaborative SIOP-RTSG, COG and ITCC session at the first SIOPE meeting

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
23
0
1

Year Published

2021
2021
2023
2023

Publication Types

Select...
8
1

Relationship

6
3

Authors

Journals

citations
Cited by 26 publications
(24 citation statements)
references
References 57 publications
0
23
0
1
Order By: Relevance
“…Lastly, the relapse setting gives us opportunities to test new drugs (that can be moved upfront in the future), and also to develop tumor models, like organoids or patient-derived xenografts. 9 …”
Section: Main Textmentioning
confidence: 99%
“…Lastly, the relapse setting gives us opportunities to test new drugs (that can be moved upfront in the future), and also to develop tumor models, like organoids or patient-derived xenografts. 9 …”
Section: Main Textmentioning
confidence: 99%
“…(11)(12)(13)(14) More recently, during the HARMONICA era, coordinated parallel manuscript/research efforts from COG/SIOP have focused on imaging surveillance, (15,16) stage 1 DAWT (17,18) and WAGR and WT. (19,20) Collaborative reviews on unmet needs in WT, (21) addressing international progress in WT, (3) WT phase 1 and 2 studies, ( 22) congenital mesoblastic nephroma, (23) renal cell carcinoma (24) Wilms tumor broadly, (25)) and more recently a comprehensive position paper on oncofertility issues pertinent to pediatric renal cancer (26) have been finalized.…”
Section: Achievements Through International Collaboration In Pediatri...mentioning
confidence: 99%
“…Radiology Diffusion weighted MRI is helpful in characterizing renal tumors Outcome of patients with CT-only lung metastasis is inferior to no metastasis Specific renal tumors require biopsy before preoperative chemotherapy ( 14), ( The basis for the current UMBRELLA study is summarized in several reviews on Nephroblastoma, 13,37,38 relapse treatment, 39,40 pathology and biology, 41 but also on different non-WTs. [42][43][44][45][46] Over the last decades collaboration and exchange of knowledge between SIOP-RTSG and the Children's Oncology Group Renal Tumor Committee has developed resulting in a number of papers such as renal tumors of early age, 47 a meta-analysis of high dose chemotherapy, 48 late relapses, 49 the advances of international collaboration 50 and new approaches to risk stratification for WT.…”
Section: Discipline Findings Literaturementioning
confidence: 99%